文献速递重症综合管理与镇静镇痛儿科与产科急症

丙泊酚与七氟烷维持麻醉与老年患者术后谵妄、认知下降及死亡率的关联:一项全球比较有效性研究

Association of propofol vs. sevoflurane maintenance anesthesia with postoperative delirium, cognitive decline, and mortality in older adults: a global comparative-effectiveness study.
PubMed 文献 · Crit Care · 2026-02-23
一句话结论在60–80岁全麻手术患者中,丙泊酚维持麻醉与七氟烷相比与更高的术后谵妄、30天死亡率、长期认知功能障碍及长期死亡率相关(观察性证据,作者认为需随机试验验证)。

这项多中心回顾性比较有效性研究利用全球联邦健康网络,纳入60–80岁接受丙泊酚或七氟烷维持全麻手术的成人,经1:1倾向评分匹配后共91,046例(丙泊酚45,545例,七氟烷45,545例),采用双重稳健Cox模型估计校正风险比。丙泊酚与更高的术后谵妄风险(3.36% vs 2.70%;aHR 1.37,95%CI 1.25–1.48)和30天死亡率(0.66% vs 0.53%;aHR 1.25,95%CI 1.05–1.48)相关,术后第1天超额风险最大(aHR 2.58)。长期认知功能障碍(aHR 1.16,95%CI 1.09–1.24)和长期死亡率(aHR 1.23,95%CI 1.17–1.29)也升高。作者认为这些发现为高危老年患者的麻醉选择提出假设,并支持开展足够把握度的随机试验。

要点

  • 匹配后91,046例60–80岁全麻手术患者中,丙泊酚组术后谵妄发生率3.36% vs 七氟烷组2.70%,aHR 1.37(95%CI 1.25–1.48)。
  • 丙泊酚组30天死亡率0.66% vs 七氟烷组0.53%,aHR 1.25(95%CI 1.05–1.48),术后第1天超额风险最大(aHR 2.58)。
  • 丙泊酚组长期认知功能障碍aHR 1.16(95%CI 1.09–1.24),长期死亡率aHR 1.23(95%CI 1.17–1.29)。
  • 作者认为这些发现为高危老年患者的麻醉选择提出假设,并支持开展足够把握度的随机试验。

适用人群与场景

  • 60–80岁接受全麻手术的成人,且术中维持使用丙泊酚或七氟烷。

研究设计与关键结果

  • 多中心回顾性比较有效性研究,使用全球联邦健康网络,经1:1倾向评分匹配后纳入91,046例患者(丙泊酚45,545例;七氟烷45,545例)。
  • 主要终点术后谵妄:丙泊酚组3.36% vs 七氟烷组2.70%,aHR 1.37(95%CI 1.25–1.48)。
  • 30天死亡率:丙泊酚组0.66% vs 七氟烷组0.53%,aHR 1.25(95%CI 1.05–1.48),术后第1天aHR 2.58。
  • 长期术后认知功能障碍(180–365天):aHR 1.16(95%CI 1.09–1.24);长期死亡率:aHR 1.23(95%CI 1.17–1.29)。
  • 敏感性分析纳入基于抗精神病药物的谵妄判定和时间分层风险。

证据类型、等级与局限

  • 证据类型:多中心回顾性比较有效性研究(观察性队列)。
  • 局限:可能漏判结局;缺乏术中生理数据;电子健康记录固有的残余混杂。

对床旁实践的改变

  • 在60–80岁全麻手术患者中,选择七氟烷而非丙泊酚维持麻醉可能与更低的术后谵妄、30天死亡率、长期认知功能障碍及长期死亡率相关,但作者认为这仅提出假设,需足够把握度的随机试验验证。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Postoperative delirium and longer-term neurocognitive disorders are major complications of surgery in older adults. As surgical volumes rise in ageing populations, identifying modifiable intraoperative factors—particularly anesthetic choice—has become increasingly important. Propofol is often favoured for its recovery profile, whereas sevoflurane offers organ-protective preconditioning that may benefit vulnerable patients. Comparative evidence in high-risk real-world populations remains limited. METHODS: We performed a multicentre retrospective comparative-effectiveness study using a global federated health network. Adults aged 60–80 year undergoing surgery with general anesthesia were included if they received propofol or sevoflurane for maintenance. Propensity-score matching (1:1) and doubly robust Cox models estimated adjusted hazard ratios (aHRs). The primary outcome was postoperative delirium; secondary outcomes were 30-day mortality, long-term postoperative cognitive dysfunction (180–365 days), and long-term mortality. Sensitivity analyses incorporated antipsychotic-based delirium ascertainment and time-stratified hazards. RESULTS: After matching, 91,046 patients were included (propofol 45,545; sevoflurane 45,545). Propofol was associated with higher risks of postoperative delirium (3.36% vs. 2.70%; aHR 1.37, 95% CI 1.25–1.48) and 30-day mortality (0.66% vs. 0.53%; aHR 1.25, 95% CI 1.05–1.48), with the greatest excess on postoperative day 1 (aHR 2.58). Long-term cognitive dysfunction (aHR 1.16, 95% CI 1.09–1.24) and long-term mortality (aHR 1.23, 95% CI 1.17–1.29) were also increased. CONCLUSIONS: In this large real-world cohort, propofol maintenance anesthesia was associated with higher risks of postoperative delirium, long-term cognitive decline, and mortality compared with sevoflurane, particularly in physiologically vulnerable patients. These findings generate hypotheses regarding anesthetic choice in high-risk older adults and support the need for adequately powered randomized trials. Limitations include potential outcome under-ascertainment, lack of intraoperative physiologic data, and residual confounding inherent to electronic health records.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Sun M, Miao M, Lu Z, et al. Association of propofol vs. sevoflurane maintenance anesthesia with postoperative delirium, cognitive decline, and mortality in older adults: a global comparative-effectiveness study. Crit Care. 2026. PMID: 41731573. doi:10.1186/s13054-026-05903-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。